Freedom Fertility Pharmacy

freedomfertility.com

Freedom Fertility Pharmacy was founded in 1973 as Freedom Drug, a New Hampshire-based community retail pharmacy. With an emphasis on individualized patient care and superior customer service, Freedom prospered and expanded, opening locations throughout New England in the 70s and 80s. In the 1990s, Freedom focused its personalized approach on a growing segment of its business, women's health and infertility. In 1994, the company relocated to Lynnfield, MA, focusing its operations exclusively on infertility and speciality pharmacy services.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

TEMPERATURE CONTROLLED PHARMACEUTICAL CONTAINERS MARKET GROWTH SALES REVENUE ANALYSIS 2019-2027

Daily Science | April 09, 2020

news image

In this report, the global Temperature Controlled Pharmaceutical Containers market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2019 to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025. The Temperature Controlled Pharmaceutical Contain...

Read More

VIEWS AND ANALYSIS

CMIC AND LOKAVANT COLLABORATE TO DEPLOY MACHINE LEARNING-POWERED CLINICAL TRIAL INTELLIGENCE PLATFORM

CMIC | June 25, 2021

news image

CMIC Co., Ltd., a leading Japanese Contract Research Organization (CRO), and Lokavant, a leading clinical trial intelligence company, announced today that they have agreed to use Lokavant's predictive analytics capabilities to assist CMIC's clinical operations. This strategic collaboration, Lokavant Oversight, monitoring, and operational risk management platform, will be implemented throughout CMIC studies. CMIC was the first firm in Japan to provide CRO services, and the ...

Read More

BUSINESS INSIGHTS

NANOLOGY PUBLISHES REVIEW ARTICLE OF PRECLINICAL AND CLINICAL RESEARCH SUPPORTING LSAM-DTX

NanOlogy | September 21, 2022

news image

NanOlogy LLC, a clinical-stage interventional oncology drug company, announced that a review article of preclinical and clinical research supporting its investigational drug, large surface area microparticle docetaxel has been published in Drug Delivery and Translational Research. The review article entitled Local administration of large surface area microparticle docetaxel to solid carcinomas induces direct cytotoxicity and immune‑mediated tumoricidal effects: preclinical and cli...

Read More

PHARMACY MARKET

A NOVEL AZAPEPTIDE EDITING METHOD PROVIDES POTENTIAL FOR NEW DRUG DEVELOPMENT, FEINSTEIN INSTITUTES RESEARCH SHOWS

Feinstein Institutes | November 29, 2022

news image

Peptides, short sections of proteins made up of chains of amino acids, are an important area of new drug development due to their potential for increased specificity and fewer side effects. Their main drawback is the rapid degradation by the body’s own enzymes, which has led to the need to develop longer-lasting peptide alternatives. Azapeptides are one type of peptide alternative that has shown great potential as therapeutics, exemplified by the HIV drug, Atazanavir. A new ...

Read More
news image

TEMPERATURE CONTROLLED PHARMACEUTICAL CONTAINERS MARKET GROWTH SALES REVENUE ANALYSIS 2019-2027

Daily Science | April 09, 2020

In this report, the global Temperature Controlled Pharmaceutical Containers market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2019 to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025. The Temperature Controlled Pharmaceutical Contain...

Read More
news image

VIEWS AND ANALYSIS

CMIC AND LOKAVANT COLLABORATE TO DEPLOY MACHINE LEARNING-POWERED CLINICAL TRIAL INTELLIGENCE PLATFORM

CMIC | June 25, 2021

CMIC Co., Ltd., a leading Japanese Contract Research Organization (CRO), and Lokavant, a leading clinical trial intelligence company, announced today that they have agreed to use Lokavant's predictive analytics capabilities to assist CMIC's clinical operations. This strategic collaboration, Lokavant Oversight, monitoring, and operational risk management platform, will be implemented throughout CMIC studies. CMIC was the first firm in Japan to provide CRO services, and the ...

Read More
news image

BUSINESS INSIGHTS

NANOLOGY PUBLISHES REVIEW ARTICLE OF PRECLINICAL AND CLINICAL RESEARCH SUPPORTING LSAM-DTX

NanOlogy | September 21, 2022

NanOlogy LLC, a clinical-stage interventional oncology drug company, announced that a review article of preclinical and clinical research supporting its investigational drug, large surface area microparticle docetaxel has been published in Drug Delivery and Translational Research. The review article entitled Local administration of large surface area microparticle docetaxel to solid carcinomas induces direct cytotoxicity and immune‑mediated tumoricidal effects: preclinical and cli...

Read More
news image

PHARMACY MARKET

A NOVEL AZAPEPTIDE EDITING METHOD PROVIDES POTENTIAL FOR NEW DRUG DEVELOPMENT, FEINSTEIN INSTITUTES RESEARCH SHOWS

Feinstein Institutes | November 29, 2022

Peptides, short sections of proteins made up of chains of amino acids, are an important area of new drug development due to their potential for increased specificity and fewer side effects. Their main drawback is the rapid degradation by the body’s own enzymes, which has led to the need to develop longer-lasting peptide alternatives. Azapeptides are one type of peptide alternative that has shown great potential as therapeutics, exemplified by the HIV drug, Atazanavir. A new ...

Read More